Frontlight ResearchEarly access
CompletedNo phase
Acute and Long-term Effects of CPAP in OSA
Key facts
- Who runs it
- University of Zurich
- Where
- Switzerland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 36 people enrolled
- Started
- 1 Feb 2021
- Ended
- 1 Jul 2024
- Type of study
- Interventional
- Treatments tested
- Continuous positive airway pressure (CPAP)
- Record updated
- 4 December 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Age ≥ 18 years
- Untreated moderate or severe OSA with an apnoea-hypopnoea-index (AHI) of ≥ 20/h and an oxygen desaturation index (>3%-dips) of ≥ 20/h in an in-laboratory sleep study
- Epworth Sleepiness Scale Score ≥7/24 points
- Indication for CPAP therapy
- Written informed consent
Who cannot take part
- Current professional driver or previous sleepiness-related accidents
- Moderate or more severe obstructive or restrictive ventilatory disorder (FEV1 or FVC < 70%)
- Heart failure
- Other types of sleep-related breathing disorders, e.g. sleep-associated hypoventilation, central sleep apnoea, Cheyne Stoke's Breathing
- Hypoxic or hypercapnic respiratory failure (awake paO2 < 9 kPa or paCO2 > 6 kPa)
- Active treatment for OSA (CPAP, mandibular advancement device, hypoglossal nerve stimulation)
- Pregnancy
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Two-phase interventional non-inferiority trial (phase 1: at least 8 weeks of CPAP; phase 2: 2 weeks of CPAP withdrawal) including 32 patients with moderate to severe OSA to compare the physiological consequences of a short-term CPAP withdrawal to the changes in previously untreated OSA. The trial has been designed as a validation of the CPAP-withdrawal model. Baseline in-laboratory sleep studies will be performed prior to CPAP initiation, after 6-8 weeks on CPAP (treatment effect) and following 2 weeks of CPAP therapy withdrawal (withdrawal effect, effect of OSA recurrence).
The group in the trial
- Single arm (therapy initiation followed by therapy withdrawal)Other group
Continuous positive airway pressure (CPAP)
Treatment: Continuous positive airway pressure (CPAP)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Acute, Intermediate and Long-term Effects of CPAP Therapy in Obstructive Sleep Apnoea: a Two-phase Interventional Trial.
- Record updated
- 4 December 2024